Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer

BACKGROUND: Platinum resistance is a major challenge in the management of ovarian cancer. Even low levels of acquired resistance at the cellular level lead to impaired response to cisplatin. In ovarian cancer intraperitoneal therapy, nanoparticle formulation can improve the cisplatin’s pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortot, Barbara, Mongiat, Maurizio, Valencic, Erica, Dal Monego, Simeone, Licastro, Danilo, Crosera, Matteo, Adami, Gianpiero, Rampazzo, Enrico, Ricci, Giuseppe, Romano, Federico, Severini, Giovanni Maria, Biffi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368240/
https://www.ncbi.nlm.nih.gov/pubmed/32764921
http://dx.doi.org/10.2147/IJN.S247114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368240/
https://www.ncbi.nlm.nih.gov/pubmed/32764921
http://dx.doi.org/10.2147/IJN.S247114

Ejemplares similares